Current directions of biologic therapies in inflammatory bowel disease.

Current directions of biologic therapies in inflammatory bowel disease.

Item
http://www.wikidata.org/entity/Q41174352
Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient managementProgress in the diagnosis and treatment of inflammatory bowel disease.Substance P mediates pro-inflammatory cytokine release form mesenteric adipocytes in Inflammatory Bowel Disease patientsRegional and mucosal memory T cells.Effect of Anti-TNF Agents on Postoperative Outcomes in Inflammatory Bowel Disease Patients: a Single Institution Experience.Pharmacogenetics of inflammatory bowel disease: a focus on Crohn's disease.Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn's disease and ulcerative colitis.Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice.A FCGR3A Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF.Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.
P2860

Current directions of biologic therapies in inflammatory bowel disease.

Item
http://www.wikidata.org/entity/Q41174352
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Current directions of biologic therapies in inflammatory bowel disease.
@en
type
label
Current directions of biologic therapies in inflammatory bowel disease.
@en
prefLabel
Current directions of biologic therapies in inflammatory bowel disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Current directions of biologic therapies in inflammatory bowel disease.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932